Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 13, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.6K

Evaluating Stacked Methylation Markers for Blood-Based Multicancer Detection.

Karen Funderburk1, Sara R Bang-Christensen1, Brendan F Miller1

  • 1Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Cancers
|October 14, 2023
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional characterization of the 9q34.13 locus identifies <i>RAPGEF1</i> as modulating risk for melanoma and nevi via RAS activation.

bioRxiv : the preprint server for biology·2026
Same author

Differential expression analysis in single-cell and spatial RNA-seq without model assumptions.

Cell reports methods·2026
Same author

Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus.

medRxiv : the preprint server for health sciences·2026
Same author

Specialized gas-exchange endothelium of the zebrafish gill.

bioRxiv : the preprint server for biology·2026
Same author

Identification of distinct functions of GLIS3 in β-cell generation critical to prevention of neonatal diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Differential expression analysis in single cell and spatial RNASeq without model assumptions.

bioRxiv : the preprint server for biology·2025
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
Same journal

Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis.

Cancers·2026
See all related articles
This summary is machine-generated.

A novel blood test using three methylation markers (TLX1, GALR1, ZNF154) shows potential for early cancer detection. This multi-cancer biomarker approach significantly improves accuracy across various tumor types in blood samples.

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Biomarker Discovery

Background:

  • Non-invasive, blood-based cancer detection is crucial for early diagnosis and improved patient outcomes.
  • Methylation markers in cell-free DNA are promising biomarkers for cancer screening.

Purpose of the Study:

  • To identify and validate novel methylation biomarkers for a multi-cancer blood test.
  • To evaluate the diagnostic performance of a three-marker panel (TLX1, GALR1, ZNF154) in diverse cancer types.

Main Methods:

  • Mining The Cancer Genome Atlas (TCGA) methylation data for novel markers.
  • Utilizing logistic regression and ROC curve analysis to assess marker performance.
  • Validating marker performance in patient tumor and plasma samples using bisulfite sequencing.
Keywords:
DNA methylationbiomarkerbisulfite sequencingcancerdiagnosticsliquid biopsymulti-cancerscreening

More Related Videos

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.7K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

Related Experiment Videos

Last Updated: Jul 13, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.6K
Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.7K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

Main Results:

  • Two novel methylation markers, TLX1 and GALR1, were identified alongside ZNF154.
  • The three-marker combination significantly improved the area under the ROC curve (AUC) across 14 cancer types.
  • The assay demonstrated potential in detecting lung cancer and hepatocellular carcinoma in patient plasma samples.

Conclusions:

  • A comprehensive pipeline for multi-cancer methylation biomarker discovery and validation was established.
  • The three-marker panel shows considerable potential for a generalized, non-invasive blood-based cancer screening test.
  • Further validation in larger patient cohorts is warranted to confirm clinical utility.